278 related articles for article (PubMed ID: 29567196)
1. Comparison of melibiose and trehalose as stabilising excipients for spray-dried β-galactosidase formulations.
Lipiäinen T; Räikkönen H; Kolu AM; Peltoniemi M; Juppo A
Int J Pharm; 2018 May; 543(1-2):21-28. PubMed ID: 29567196
[TBL] [Abstract][Full Text] [Related]
2. Spray-dried amorphous isomalt and melibiose, two potential protein-stabilizing excipients.
Lipiäinen T; Peltoniemi M; Räikkönen H; Juppo A
Int J Pharm; 2016 Aug; 510(1):311-22. PubMed ID: 27321131
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of IgG1 in spray-dried powders for inhalation.
Schüle S; Schulz-Fademrecht T; Garidel P; Bechtold-Peters K; Frieb W
Eur J Pharm Biopharm; 2008 Aug; 69(3):793-807. PubMed ID: 18477504
[TBL] [Abstract][Full Text] [Related]
4. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
[TBL] [Abstract][Full Text] [Related]
5. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
[TBL] [Abstract][Full Text] [Related]
6. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
[TBL] [Abstract][Full Text] [Related]
7. Stability of rituximab in freeze-dried formulations containing trehalose or melibiose under different relative humidity atmospheres.
Heljo VP; Filipe V; Romeijn S; Jiskoot W; Juppo AM
J Pharm Sci; 2013 Feb; 102(2):401-14. PubMed ID: 23192744
[TBL] [Abstract][Full Text] [Related]
8. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.
Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123
[TBL] [Abstract][Full Text] [Related]
9. Tableting behavior of freeze and spray-dried excipients in pharmaceutical formulations.
Madi C; Hsein H; Busignies V; Tchoreloff P; Mazel V
Int J Pharm; 2024 May; 656():124059. PubMed ID: 38552753
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders.
Yu J; Romeo MC; Cavallaro AA; Chan HK
Int J Pharm; 2018 Apr; 541(1-2):11-18. PubMed ID: 29454904
[TBL] [Abstract][Full Text] [Related]
11. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
[TBL] [Abstract][Full Text] [Related]
12. Peptide Isolation via Spray Drying: Particle Formation, Process Design and Implementation for the Production of Spray Dried Glucagon.
Doerr FJS; Burns LJ; Lee B; Hinds J; Davis-Harrison RL; Frank SA; Florence AJ
Pharm Res; 2020 Dec; 37(12):255. PubMed ID: 33319329
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the physical properties of spray-dried stabilised lysozyme particles.
Liao YH; Brown MB; Quader A; Martin GP
J Pharm Pharmacol; 2003 Sep; 55(9):1213-21. PubMed ID: 14604464
[TBL] [Abstract][Full Text] [Related]
14. Stabilizing effect of four types of disaccharide on the enzymatic activity of freeze-dried lactate dehydrogenase: step by step evaluation from freezing to storage.
Kawai K; Suzuki T
Pharm Res; 2007 Oct; 24(10):1883-90. PubMed ID: 17486434
[TBL] [Abstract][Full Text] [Related]
15. The use of hydrophobic amino acids in protecting spray dried trehalose formulations against moisture-induced changes.
Mah PT; O'Connell P; Focaroli S; Lundy R; O'Mahony TF; Hastedt JE; Gitlin I; Oscarson S; Fahy JV; Healy AM
Eur J Pharm Biopharm; 2019 Nov; 144():139-153. PubMed ID: 31536784
[TBL] [Abstract][Full Text] [Related]
16. The effect of process and formulation variables on the properties of spray-dried beta-galactosidase.
Broadhead J; Rouan SK; Hau I; Rhodes CT
J Pharm Pharmacol; 1994 Jun; 46(6):458-67. PubMed ID: 7932040
[TBL] [Abstract][Full Text] [Related]
17. Instability of bacteriophages in spray-dried trehalose powders is caused by crystallization of the matrix.
Vandenheuvel D; Meeus J; Lavigne R; Van den Mooter G
Int J Pharm; 2014 Sep; 472(1-2):202-5. PubMed ID: 24950368
[TBL] [Abstract][Full Text] [Related]
18. Application of cyclodextrins in antibody microparticles: potentials for antibody protection in spray drying.
Ramezani V; Vatanara A; Seyedabadi M; Nabi Meibodi M; Fanaei H
Drug Dev Ind Pharm; 2017 Jul; 43(7):1103-1111. PubMed ID: 28276783
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of excipients for enhanced thermal stabilization of a human type 5 adenoviral vector through spray drying.
LeClair DA; Cranston ED; Xing Z; Thompson MR
Int J Pharm; 2016 Jun; 506(1-2):289-301. PubMed ID: 27130366
[TBL] [Abstract][Full Text] [Related]
20. Do co-spray dried excipients offer better lysozyme stabilisation than single excipients?
Hulse WL; Forbes RT; Bonner MC; Getrost M
Eur J Pharm Sci; 2008 Mar; 33(3):294-305. PubMed ID: 18262776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
